Straumann (SAUHY) Stock Price, News & Analysis

Company Overview

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows. These include CAD/CAM-compatible components, digital prosthetics, and software and scanning technologies designed to integrate clinical and laboratory processes. The company also supplies adjunctive tools and instruments, clinical training, and technical support aimed at improving treatment predictability and practice efficiency.

Headquartered in Basel, Switzerland, Straumann serves a global customer base of dental clinicians, laboratories and distributors across Europe, the Americas and the Asia-Pacific region. The company emphasizes research and development, clinical evidence and partnerships with academic and clinical institutions to advance implantology and restorative dentistry. Straumann’s products and services are positioned to address trends toward digital workflows, minimally invasive procedures and comprehensive restorative care.

Straumann is publicly traded and its securities trade internationally, including via the OTC market under the symbol SAUHY. The company’s strategic focus remains on innovation, expanding clinical education and broadening its product portfolio to support dental professionals and improve patient outcomes worldwide.

Key Stats

• Today's Range: $11.62 to $12.33
• 50-Day Range: $9.45 to $12.10
• 52-Week Range: $9.44 to $14.11
• Volume: 176,415 shs
• Average Volume: 101,716 shs
• Market Capitalization: $19.29 billion
• P/E Ratio: N/A
• Dividend Yield: 0.50%
• Price Target: N/A
• Consensus Rating: Reduce

Straumann Stock Analysis - MarketRank™

Straumann scored higher than 32% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.3 / 5
• Analyst Rating: Reduce

Consensus Rating

Straumann has received a consensus rating of Reduce. The company's average rating score is 1.80, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and 2 sell ratings.

Amount of Analyst Coverage

Straumann has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 20.00%

Earnings Growth

Earnings for Straumann are expected to grow by 20.00% in the coming year, from $0.40 to $0.48 per share.

Price to Earnings Growth Ratio

Straumann has a PEG Ratio of 2.52. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Straumann has a P/B Ratio of 7.38. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of Straumann has been sold short.

Short Interest Ratio / Days to Cover

Straumann has a short interest ratio ("days to cover") of 0.91, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Straumann has recently increased by 329.51%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Straumann has a dividend yield of 0.47%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Straumann does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Straumann will have a dividend payout ratio of 12.50% next year. This indicates that Straumann will be able to sustain or increase its dividend.

News and Social Media

• Score: 1.2 / 5
• News Sentiment: -0.01

News Sentiment

Straumann has a news sentiment score of -0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.83 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Straumann this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Straumann insiders have not sold or bought any company stock.

Percentage Held by Institutions

Straumann has minimal institutional ownership at this time.

Company Calendar

• Today: 5/31/2026
• Next Earnings (Estimated): 8/19/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED/DENTAL - SUPP
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SAUHY
• Previous Symbol: OTCMKTS:SAUHY
• CIK: 1451279
• Web: www.straumann.com
• Phone: (161) 965-1111
• Fax: 41-61-965-1001
• Employees: 11,319
• Year Founded: 1954

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 30.25
• P/E Growth: 2.52
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.21
• Quick Ratio: 1.57

Sales & Book Value

• Annual Sales: $3.14 billion
• Price / Sales: 6.14
• Cash Flow: $0.48 per share
• Price / Cash Flow: 25.23
• Book Value: $1.64 per share
• Price / Book: 7.38

Miscellaneous

• Outstanding Shares: 1,594,550,000
• Free Float: N/A
• Market Cap: $19.29 billion
• Optionable: Not Optionable
• Beta: 1.58